CorTec achieves first-in-human use of Brain Interchange closed-loop BCI in stroke patient
Summary
German BCI company CorTec achieved first-in-human implantation of their Brain Interchange system in a stroke patient in 2025. The fully wireless, closed-loop implant is capable of recording and stimulating the cortex in real time without any transcutaneous cables. CorTec is positioning Brain Interchange as a European competitor to Neuralink and Precision Neuroscience, operating under CE mark regulatory strategy rather than pursuing FDA first.
Why it matters
Europe now has its own cortical BCI in human use for the first time. CorTec's first-in-human data will be closely watched by European neurologists, regulators, and investors as the continent's answer to US BCI dominance. A European-developed closed-loop cortical BCI could accelerate EU regulatory framework development significantly.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial